Reference
Kapur S, et al. New onset of Juvenile Dermatomyositis during Tumor Necrosis Factor Inhibitor (Adalimumab) Therapy. Indian Journal of Rheumatology 17: 86-88, No. 1, Jan 2022. Available from: URL: http://doi.org/10.4103/injr.injr_266_20
Rights and permissions
About this article
Cite this article
Adalimumab. Reactions Weekly 1927, 21 (2022). https://doi.org/10.1007/s40278-022-24757-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-24757-4